AAN2024- Brutons Tyrsonie Kinase Inhibitor This week we have the American Academy of Neurology. In terms of what’s round the corner…there is quite a number of presentations on ozanimod which is a sphingosine-1-phosphate receptor modulator that inhibits lymphocyte migration due to activity on the S1P1 receptor and hopefully supports remyelination due to activity at S1P5 receptor. This is available already […]
https://multiple-sclerosis-res....earch.org/2024/04/aa